Cummings Keith Lamont 4
4 · PLIANT THERAPEUTICS, INC. · Filed Jun 12, 2023
Insider Transaction Report
Form 4
Cummings Keith Lamont
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-06-09$2.08/sh+5,800$12,064→ 154,270 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-06-09−5,800→ 127,797 totalExercise: $2.08Exp: 2029-01-24→ Common Stock (5,800 underlying)
Footnotes (1)
- [F1]25% of the shares subject to such option vested on December 31, 2019 and 1/48th of the shares subject to the option vested in substantially equal monthly installments thereafter, all of which were subject to the Reporting Person's continuous service to the Issuer on each such date.